Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS Australia (SA) Inc
 
 
Facebook
 
ME/CFS AUSTRALIA (SA) INC

Registered Charity 3104

Email:
sacfs@sacfs.asn.au

Mailing address:
PO Box 28,
Hindmarsh,
South Australia 5007

Office:
Suite 506,
North Terrace House,
19 North Terrace,
Hackney, SA, 5069


Phone:
1300 128 339

Office Hours:
Wednesdays, 11am-3pm

ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
PDF Application Form (PDF, 242KB)
Why become a member?

Identification of subgroups among Fibromyalgia patients

Friday 5 October 2012

 

From Italian journal Reumatismo (via ProHealth):

 

ReumatismoIdentification of subgroups among fibromyalgia patients – Source: Reumatismo, Sep 2012

By Bernard Auvinet, Denis Chaleil • ProHealth.com • October 2, 2012

[Note: This open-access paper (on how three types of CNS-related gait dysfunction correlate with other symptoms) is part of a special fibromyalgia issue of Reumatismo, the official journal of the Italian Society for Rheumatology. To read this & the other papers in English, CLICK HERE.]

This paper presents some hypotheses concerning the identification of homogeneous subgroups among fibromyalgia (FM) patients in order to improve the management of the disease. It also reviews the available literature about this subject.

Three methods for subgrouping are discussed according to clinical features, biomarkers, and gait analysis.

Clinical subgrouping based on cluster analysis has been used for the identification of homogeneous subgroups of patients and, more recently, homogeneous clinical features. So far, longitudinal studies using clinical subgroups to direct treatment and predict outcome are still required.

Biomarkers in FM, which is a neurobiological disease, are of promising interest, nevertheless currently, none of them can be used to subgroup FM patients.

• Due to the fact that cortical and subcortical mechanisms of gait control share some cognitive functions which are involved in FM, gait markers have been proposed to evaluate and to subgroup FM patients, in clinical settings. Three out of 4 core FM symptoms are linked to gait markers.

• Kinesia [muscle movement] measured by means of cranio-caudal power is correlated topain, and could be proposed to assess pain behavior (kinesiophobia).

• Stride frequency, which is linked to physical component, allows the identification of a hyperkinetic subgroup. Moreover, SF has been correlated to fatigue during the 6 minute walking test.

• Stride regularity, which expresses the unsteadiness of gait, is correlated to cognitive dysfunction in FM. Decreased stride regularity allows the recognition of a homogeneous subgroup characterized by an increased anxiety and depression, and decreased cognitive functions.

These results need further studies to be validated and so used in the daily clinical practice.

Source: Reumatismo. 2012 Sep 28;64(4):250-60. PMID: 23024969, Auvinet B, Chaleil D. Polyclinique du Maine, Laval Cedex; Department of Pharmacy, University Hospital, Angers, France. [Email: bernard.auvinet@gmail.com]

 

The above originally appeared here.

 


Arrow right

More Fibromyalgia News

 


 

blog comments powered by Disqus
Previous Previous Page